Division of Hematology and Medical Oncology

To deliver highly specialized and coordinated care, the Division of Hematology and Medical Oncology is structured into disease-specific subspecializations that focus on a broad spectrum of cancers and hematologic disorders—including breast, brain, gastrointestinal, gynecologic, head and neck, lung, skin, prostate, and blood cancers, as well as complex conditions such as leukemia, lymphoma, sickle cell disease, and other rare syndromes. Each team brings focused expertise and works collaboratively within a multidisciplinary framework that includes surgical oncologists, radiation oncologists, radiologists, pathologists, and supportive care professionals. Through robust tumor boards and evidence-based protocols, we develop individualized treatment plans that reflect the latest advances in cancer care and drive innovation across the continuum of oncology practice.

We offer cutting-edge programs such as cellular therapy and precision oncology, which harness the power of genomics and immunotherapy to tailor treatments to each patient’s unique disease profile. These therapies are delivered in a highly coordinated environment with rigorous safety protocols, advanced monitoring, and access to supportive services that optimize recovery and long-term health. Our clinical trials portfolio is extensive, providing patients with access to novel therapies and contributing to the advancement of cancer care nationwide.